Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Oct;8(1):e001252.
doi: 10.1136/bmjdrc-2020-001252.

Additive effects of green tea and coffee on all-cause mortality in patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry

Affiliations

Additive effects of green tea and coffee on all-cause mortality in patients with type 2 diabetes mellitus: the Fukuoka Diabetes Registry

Yuji Komorita et al. BMJ Open Diabetes Res Care. 2020 Oct.

Abstract

Introduction: The impact of consuming green tea or coffee on mortality in patients with diabetes is controversial. We prospectively investigated the impact of each beverage and their combination on mortality among Japanese patients with type 2 diabetes.

Research design and methods: In all, 4923 patients (2790 men, 2133 women) with type 2 diabetes (mean age, 66 years) were followed prospectively (median, 5.3 years; follow-up rate, 99.5%). We evaluated the amount of green tea and coffee consumed using self-administered questionnaires.

Results: During the follow-up period, 309 participants died. The consumption of green tea, coffee, and a combination of the beverages was associated with reduced all-cause mortality. Multivariable-adjusted hazard ratios (95% CIs) for green tea were as follows: none 1.0 (referent); 0.85 (0.60-1.22) for ≤1 cup/day; 0.73 (0.51-1.03) for 2-3 cups/day; 0.60 (0.42-0.85) for ≥4 cups/day; and P for trend, 0.002. For coffee, they were: none 1.0 (referent); 0.88 (0.66-1.18) for <1 cup/day; 0.81 (0.58-1.13) for 1 cup/day; 0.59 (0.42-0.82) for ≥2 cups/day; P for trend, 0.002. With the combination they were 1.0 (referent) for no consumption of green tea and coffee; 0.49 (0.24-0.99) for 2-3 cups/day of green tea with ≥2 cups/day of coffee; 0.42 (0.20-0.88) for ≥4 cups/day of green tea with 1 cup/day of coffee; and 0.37 (0.18-0.77) for ≥4 cups/day of green tea with ≥2 cups/day of coffee.

Conclusions: Higher consumption of green tea and coffee was associated with reduced all-cause mortality: their combined effect appeared to be additive in patients with type 2 diabetes.

Keywords: green tea catechin; mortality; nutritional epidemiology; type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Combined effects of green tea and coffee consumption on all-cause mortality in patients with type 2 diabetes. The estimates are adjusted for age, sex, BMI, diabetes duration, current smoking habit, current alcohol intake, LTPA, sleep duration, HbA1c, UACR, systolic blood pressure, LDL cholesterol, history of CVD and cancer. *P<0.05 vs the reference group (NO consumption of green tea and coffee). BMI, body mass index; CVD, cardiovascular disease; HbA1c, hemoglobin A1c; LDL, low-density lipoprotein; LTPA, leisure-time physical activity; UACR, urinary albumin creatinine ratio.

Similar articles

Cited by

References

    1. Guariguata L, Whiting DR, Hambleton I, et al. . Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014;103:137–49. 10.1016/j.diabres.2013.11.002 - DOI - PubMed
    1. Kirkman MS, Briscoe VJ, Clark N, et al. . Diabetes in older adults. Diabetes Care 2012;35:2650–64. 10.2337/dc12-1801 - DOI - PMC - PubMed
    1. American Diabetes Association 5. Lifestyle Management: Standards of Medical Care in Diabetes–2019. Diabetes Care 2019;42:S46–60. 10.2337/dc19-S005 - DOI - PubMed
    1. Schneider C, Segre T. Green tea: potential health benefits. Am Fam Physician 2009;79:591–4. - PubMed
    1. Boehm K, Borrelli F, Ernst E, et al. . Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev 2009:Cd005004. 10.1002/14651858.CD005004.pub2 - DOI - PMC - PubMed

Publication types